3β,7α,25-Trihydroxy-5-cholestenoic acid
| Catalog Number | BL-M001310 |
| CAS Number | 2192191-62-9 |
| Description | 3β,7α,25-Trihydroxy-5-cholestenoic acid, a compound derived from bile acids, plays a pivotal role in modulating cholesterol and lipid metabolism. Its therapeutic application extends to liver ailments and dyslipidemia-linked conditions, offering potential avenues for ameliorating metabolic perturbations. |
| IUPAC Name | (6R)-6-[(3S,7S,10R,13R,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-hydroxy-2-methylheptanoic acid |
| Synonyms | Cholest-5-en-26-oic acid, 3β,7α,25-trihydroxy-; 3beta,7alpha,25-Trihydroxy-5-cholestenoic acid; Cholest-5-en-26-oic acid, 3beta,7alpha,25-trihydroxy- |
| Molecular Weight | 448.64 |
| Molecular Formula | C27H44O5 |
| Purity | >99% |
| Solubility | Soluble in Chloroform, Methanol, Water |
| Appearance | White Solid |
| Shelf Life | 1 Year |
| Storage | Store at -20°C |
| Percent Composition | C 72.28%, H 9.89%, O 17.83% |
| Canonical SMILES | CC(CCCC(C)(C(=O)O)O)C1CCC2C1(CCC3C2C(C=C4C3(CCC(C4)O)C)O)C |
| InChI | InChI=1S/C27H44O5/c1-16(6-5-11-27(4,32)24(30)31)19-7-8-20-23-21(10-13-26(19,20)3)25(2)12-9-18(28)14-17(25)15-22(23)29/h15-16,18-23,28-29,32H,5-14H2,1-4H3,(H,30,31)/t16-,18+,19-,20?,21?,22-,23?,25+,26-,27?/m1/s1 |
| InChI Key | UOADYMQCTKNNPV-NMRWGJHFSA-N |
※ Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Related Products
Online Inquiry
